A Pfizer case study published in July 2018 by José-Miguel Montenegro-Alvarado, et. al. highlights the benefits provided by rapid microbial methods in evaluating risks and expediting recovery after a hurricane. View the publication here to see how rapid microbial methods, including the BAMS are being used within industry.

Learn More:

https://www.pharmaceuticalonline.com/doc/pfizer-case-study-rapid-microbial-methods-for-manufacturing-recovery-after-hurricane-mar-a-0001